Código QR

Evaluation of the cardiopulmonary effects of repurposed COVID-19 therapeutics in healthy rats

Abstract Hydroxychloroquine (HCLQ), favipiravir (FAVI), molnupiravir (MOL) and dexamethasone (DEX) are recently used drugs, some of which are currently used in the treatment of Coronavirus Disease (COVID-19). We aimed to investigate the cardiovascular and pulmonary effects of MOL, HCLQ, FAVI and DEX...

ver descrição completa

Na minha lista:
Principais autores: Onural Ozhan, Azibe Yildiz, Busra Bakar, Ahmet Ulu, Zeynep Kucukakcali, Elif Karaca, Nigar Vardi, Burhan Ates, Hakan Parlakpinar
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Portfolio 2026-01-01
Colecção:Scientific Reports
Assuntos:
COVID-19
Hydroxychloroquine
Favipiravir
Molnupiravir
Dexamethasone
Acesso em linha:https://doi.org/10.1038/s41598-025-31048-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados